Inactive Instrument

Vyant Bio, Inc.

VYNT

US92942V2088

Vyant Bio, Inc.(NasdaqCM:VYNT) dropped from S&P TMI Index

May 17, 2023 at 12:00 am EDT

Latest news about Vyant Bio, Inc.

Vyant Bio, Inc. Estimates Liquidation Payments to its Shareholders	Nov. 10	CI
Vyant Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16	CI
Vyant Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-31	CI
AxoSim, Inc. entered into an agreement to acquire microBrain?-associated assets from Vyant Bio, Inc. for $3.5 million.	23-07-16	CI
Vyant Bio, Inc.(NasdaqCM:VYNT) dropped from S&P TMI Index	23-05-17	CI
Vyant Bio, Inc.(OTCPK:VYNT) dropped from NASDAQ Composite Index	23-05-12	CI
Top Midday Decliners	23-04-25	MT
Vyant Bio to Voluntarily Delist From Nasdaq, Deregister From SEC; Shares Slide After Hours	23-04-24	MT
Vyant Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Vyant Bio, Inc. Auditor Raises 'Going Concern' Doubt	23-03-30	CI
HC Wainwright Downgrades Vyant Bio to Neutral From Buy	23-02-03	MT
Vyant Bio CEO to Step Down, Successor Named; Cuts Staff as Strategic Review Process Gets Underway	23-02-03	MT
Vyant Bio, Inc. Announces Executive Changes	23-02-03	CI
Vyant Bio, Inc. Announces CEO Changes	23-02-03	CI
Strong Labor Data in Spotlight After Hawkish Fed Minutes, US Equity Futures Turned Lower Ahead of Opening Bell	23-01-05	MT
Top Premarket Gainers	23-01-05	MT
Vyant Bio Taps LifeSci Capital to Assist in Review of Strategic Options	23-01-05	MT
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives	23-01-03	CI
Top Premarket Decliners	22-12-29	MT
Vyant Bio, Inc. Terminates the Employment Contract of Ralf Brandt, Ph.D. Effective December 31, 2022	22-12-05	CI
Transcript : Vyant Bio, Inc., Nine Months 2022 Earnings Call, Nov 16, 2022	22-11-16
Earnings Flash (VYNT) VYANT BIO Reports Q3 Revenue $152,000	22-11-15	MT
Vyant Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Vyant Bio, Inc. to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16, 2022	22-11-10	CI
Reaction Biology Corporation acquired vivoPharm, LLC from Vyant Bio, Inc. for approximately $6 million.	22-11-02	CI

Vyant Bio, Inc. has no continuing operating activities other than the winddown and closure of its business. The Company is seeking to obtain its shareholdersâ approval for the voluntary liquidation and dissolution of the Company, pursuant to a plan of liquidation and dissolution.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+137.37%	5.68B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.27%	819M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+21.31%	552M

Shell Companies

Vyant Bio, Inc.

Equities

VYNT

US92942V2088

Investment Holding Companies

Vyant Bio, Inc.(NasdaqCM:VYNT) dropped from S&P TMI Index

Latest news about Vyant Bio, Inc.

Chart Vyant Bio, Inc.

Company Profile

Sector Shell Companies